Flu, RSV, and COVID Antiviral Agents

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/22

encourage image

There's no tags or description

Looks like no tags are added yet.

23 Terms

1
New cards

Adamantanes MOA

Block the M2 ion channel to inhibit viral uncoating

2
New cards

Adamantanes indications

Influenza A

3
New cards

Adamantanes adverse effects

CNS effects

4
New cards

Neuraminidase inhibitors

oseltamivir

5
New cards

Neuraminidase inhibitors MOA

inhibits neuraminidase enzyme which affects the release of viral particle, thereby reducing the amount of virus in the body

6
New cards

Neuraminidase indications

influenza A and B

7
New cards

RSV Monoclonal antibody

palivizumab

nirsevimab

clesrovimab

8
New cards

RSV monoclonal Antibody indications

less than 24 months old, high risk for severe disease

9
New cards

Remdesivir indications

COVID-19

10
New cards

Remdesivir MOA

adenosine nucleotide prodrug, inhibits RNA polymerase

11
New cards

Baricitinib indications

COVID-19 hospitalized patients requiring mechanical ventilation or extracorporeal membrane oxygenation (ECMO)

12
New cards

Baricitinib MOA

Inhibitor of Janus Kinase (JAK)

13
New cards

Baricitinib adverse effects

MI, sudden death, GI perforation, thrombosis

14
New cards

Monoclonal Antibodies MOA

bind to receptor binding domain of SARS-CoV-2 spike protein, not useful for Omnicron, many not authorized for use

15
New cards

Monoclonal Antibodies drugs still used

Tocilizumab and Sarilumab, IL-6 receptor inhibitors

16
New cards

Vilobelimab indicated use

COVID-19 hospitalized adults when initiated within 48 hours of receiving invasive mechanical ventilation or ECMO

17
New cards

Ritonavir-boosted nirmatrelvir indications

1st line treatment for mild to moderate COVID in people 12+ at high risk for severe illness

18
New cards

Ritonavir-boosted nirmatrelvir MOA

inhibitor of SARS-CoV-2 main protease

19
New cards

Ritonavir-boosted nirmatrelvir adverse effects

GI, altered taste, hepatitis, increase transaminase

20
New cards

Ensitrelvir MOA

SARS-CoV-2 main protease

21
New cards

Ensitrelvir indications

post exposure prophylaxis in people ages 12+ following contact with an individual who has COVID-19

22
New cards

Ensitrelvir contraindications

Pregnancy, below 12 y/o

23
New cards

Indications for COVID-19 vaccines

65+, or 6 months + for high risk people